Thymic dendritic cells are primary targets for the oncogenic virus SL3-3

被引:7
|
作者
Uittenbogaart, CH [1 ]
Law, W
Leenen, PJM
Bristol, G
van Ewijk, W
Hays, EF
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Immunol & Microbiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, Ctr Interdisciplinary Res Immunol Dis, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[6] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1128/JVI.72.12.10118-10125.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The murine retrovirus SL3-3 causes malignant transformation of thymocytes and thymic lymphoma in mice of the AKR and NFS strains when they are inoculated neonatally. The objective of the present study was to identify the primary target cells for the virus in the thymuses of these mice. Immunohistochemical studies of the thymus after neonatal inoculation of the SL3-3 virus showed that cells expressing the viral envelope glycoprotein (gp70(+) cells) were first seen at 2 weeks of age. These virus-expressing cells were found in the cortex and at the corticomedullary junction in both mouse strains. The gp70(+) cells had the morphology and immunophenotype of dendritic cells. They lacked macrophage-specific antigens. Cell separation studies showed that bright gp70(+) cells were detected in a fraction enriched for dendritic cells. At 3 weeks of age, macrophages also expressed gp70. At that time, both gp70(+) dendritic cells and macrophages were found at the corticomedullary junction and in foci in the thymic cortex. At no time during this 3-week period was the virus expressed in cortical and medullary epithelial cells or in thymic lymphoid cells. Infectious cell center assays indicated that cells expressing infectious virus were present in small numbers at 2 weeks after inoculation but increased at 5 weeks of age by several orders of magnitude, indicating virus spread to the thymic lymphoid cells. Thus, at 2 weeks after neonatal inoculation of SL3-3, thymic dendritic cells are the first cells to express the virus. At 3 weeks of age, macrophages also express the virus. In subsequent weeks, the virus spreads to the thymocytes. This pathway of virus expression in the thymus allows the inevitable provirus integration in a thymocyte that results in a clonal lymphoma.
引用
收藏
页码:10118 / 10125
页数:8
相关论文
共 50 条
  • [21] An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo
    Ethelberg, S
    Sorensen, AB
    Schmidt, J
    Luz, A
    Pedersen, FS
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9796 - 9799
  • [22] Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer
    Ethelberg, S
    Tzschaschel, BD
    Luz, A
    Diaz-Cano, SJ
    Pedersen, FS
    Schmidt, J
    JOURNAL OF VIROLOGY, 1999, 73 (12) : 10406 - 10415
  • [23] Gene expression profiling identifies oncogenic molecular pathways in T-lymphoma induction by SL3-3 retrovirus insertional mutagenesis in inbred NMRI mice.
    Dybkaer, K
    Sorensen, KD
    Schmidt, J
    d'Amore, F
    Pedersen, FS
    BLOOD, 2005, 106 (11) : 843A - 843A
  • [24] Sequence tags of provirus integration sites in DNAs of tumors induced by the murine retrovirus SL3-3
    Sorensen, AB
    Duch, M
    Amtoft, HW
    Jorgensen, F
    Pedersen, FS
    JOURNAL OF VIROLOGY, 1996, 70 (06) : 4063 - 4070
  • [25] Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer
    Sosa, MAG
    DeGasperi, R
    Undevia, S
    Yeretsian, J
    Rouse, SC
    Lyerla, T
    Kolodny, EH
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (03) : 766 - 771
  • [26] Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants
    Amtoft, HW
    Sorensen, AB
    Bareil, C
    Schmidt, J
    Luz, A
    Pedersen, FS
    JOURNAL OF VIROLOGY, 1997, 71 (07) : 5080 - 5087
  • [27] BINDING OF SL3-3 ENHANCER FACTOR-I TRANSCRIPTIONAL ACTIVATORS TO VIRAL AND CHROMOSOMAL ENHANCER SEQUENCES
    THORNELL, A
    HALLBERG, B
    GRUNDSTROM, T
    JOURNAL OF VIROLOGY, 1991, 65 (01) : 42 - 50
  • [28] Human dendritic cells as targets of dengue virus infection
    Marovich, M
    Grouard-Vogel, G
    Louder, M
    Eller, M
    Sun, W
    Wu, SJ
    Putvatana, R
    Murphy, G
    Tassaneetrithep, B
    Burgess, T
    Birx, D
    Hayes, C
    Schlesinger-Frankel, S
    Mascola, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2001, 6 (03) : 219 - 224
  • [29] TRANSCRIPTION FACTORS AND ENHANCER DNA-SEQUENCES MEDIATING DIFFERENTIAL EXPRESSION IN LYMPHOCYTES FROM THE RETROVIRUS SL3-3
    HALLBERG, B
    THORNELL, A
    GRUNDSTROM, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 142 - 142
  • [30] Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph
    Hemati, Behzad
    Contreras, Vanessa
    Urien, Celine
    Bonneau, Michel
    Takamatsu, Haru-Hisa
    Mertens, Peter P. C.
    Breard, Emmanuel
    Sailleau, Corinne
    Zientara, Stephan
    Schwartz-Cornil, Isabelle
    JOURNAL OF VIROLOGY, 2009, 83 (17) : 8789 - 8799